FDA to address backlog in processing application
The Food and Drug Administration (FDA) said it will take “drastic moves” to address the backlog in the processing of various applications as part of its efforts to create more efficient systems and to get rid of so-called “nuisance applications.”
To be specific, FDA Director-General Nela Charade Puno said she is issuing a directive which will lead to the immediate disposition of all applications for food and drug products that have been pending with the FDA for a period of six months or more.
“Starting September this year, applications for license to operate and product registration pending with the FDA for a period of six months or more will be approved provided they have fully complied with the requirements, including the payment of fees,” Puno said in a statement cited in a Manila Bulletin report.
“This will clear the way for the implementation of a better system for filing and processing of applications and the claiming of approved permits and certificates of product registration (CPR),” she added.
Puno announced that permits and CPRs granted through this initiative will still be subjected to back-end checks “following safety nets we have put in place to protect public health and well-being.”
She clarified that this is a “one-time procedure” and will be completed by the last quarter of this year.